A new study by University of Kentucky College of Medicine researchers outlines a medication plan that may be a key to treating those suffering from opioid use disorder. The research was presented at IDWeek, the joint annual meeting of the Infectious Diseases Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), the HIV Medical Association (HIVMA), the Pediatric Infectious Diseases Society (PIDS) and the Society of Infectious Diseases Pharmacists (SIDP).
“Our intervention is about linking patients with IV drug use associated infections to outpatient addiction treatment services,” says Sarah R. Blevins, a UK HealthCare pharmacist and the lead on the study, who has also helped treat those with Hepatitis C and human immunodeficiency virus (HIV).
In 2018, UK HealthCare reported 400 cases of endocarditis, an infection of the inner lining of the heart chamber and valves, of which 73% were injection drug use-associated infections. To curb overdose deaths, ease the financial burden on health care, and improve patient outcomes, the researchers worked with patients who need tools for recovery from opioid use disorder, such as mental health therapists, relapse-prevention services, and necessary medications.
“All of this goes back to the issue of addiction,” says Alice Thornton, UK College of Medicine’s chief of the Division of Infectious Disease. “We have to step back and see the whole person and the root of the problem.”
Kentucky ranks in the top five states in the nation for opioid overdose deaths, and this treatment approach may be a model for other states with large rural populations. Access to opioid use disorder treatment in Kentucky and much of the U.S. is limited. Poverty, unemployment, and legal issues are barriers, as well as transportation to treatment for those who live in rural areas—an issue that researchers say came up frequently regarding their patients. Limited access to clinics due to COVID-19-related closings has been a challenge to treatment recently.
The research outlines a comprehensive program by infectious disease providers for patients who would otherwise be discharged without follow-up for opioid use disorder. The ongoing analysis by the researchers will include a longitudinal review of patient progress and outcomes, including hospital readmission and a study to determine patients’ perceived effects on their quality of life.
“We have seen some really good success stories beyond just good health outcomes,” says Blevins. “When we hear about a former patient who has been able to reunite with their family or begin a new career, it’s rewarding.”
Opioid use disorder medications improve health outcomes after endocarditis hospitalization
83 – A Descriptive Analysis of a Multi-disciplinary Approach to Opioid Use Disorder Treatment Within an Infectious Diseases Clinic. www.eventscribe.net/2020/IDWee … resentationID=775626
Study shows multidisciplinary approach successful in curbing opioid use (2020, October 28)
retrieved 28 October 2020
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022